Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
International Journal of Chronic Obstructive Pulmonary Disease
Volume 19, 2024 - Issue
ORIGINAL RESEARCH
Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States
, , 
, , &
Mary G Johnson2 Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USAhttps://orcid.org/0000-0002-1115-0472View further author information
https://orcid.org/0000-0002-1115-0472View further author information, Scott H Bunner2 Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USAhttps://orcid.org/0000-0003-3280-5164View further author information
https://orcid.org/0000-0003-3280-5164View further author information, & Kristi K DiRocco3 USA, Medical Affairs, GSK, Collegeville, PA, USACorrespondence[email protected]
https://orcid.org/0009-0006-2988-5684View further author information
https://orcid.org/0009-0006-2988-5684View further author information